drugset / Trial / NCT03267329
Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to evaluate effect and safety on central blood pressure with Duowell compared to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.
Timeline
- Start
- 2017-09-11
- Primary completion
- 2020-09-02
- Completion
- 2020-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Comparator | Telmisartan | Other / unclassified | 80 mg | — |